Points to consider in the development of national human genome editing policy

Camb Prism Precis Med. 2023 Mar 27:1:e23. doi: 10.1017/pcm.2023.11. eCollection 2023.

Abstract

Clustered regularly interspaced short palindromic repeats and other genome editing technologies have the potential to transform the lives of people affected by genetic disorders for the better. However, it is widely recognised that they also raise large ethical and policy questions. The focus of this article is on how national genome editing policy might be developed in ways that give proper recognition to these big questions. The article first considers some of the regulatory challenges involved in dealing these big ethical and social questions, and also economic issues. It then reviews the outcomes of a series of major reports on genome editing from international expert bodies, with a particular focus on the work of the World Health Organization's expert committee on genome editing. The article then summarises five policy themes that have emerged from this review of the international reports together with a review of other literature, and the authors' engagement with members of the Australian public and with a wide range of experts across multiple disciplines. Each theme is accompanied by one to three pointers for policymakers to consider in developing genome editing policy.

Keywords: Heritable human genome editing; citizen engagement; genome editing policy; genome editing regulation; non-heritable human genome editing.

Publication types

  • Review